Jim Cramer's top 10 things to watch in the stock market Wednesday
Moderna is soaring after promising results for its cancer vaccine. Plus, Target may be victim to profit-taking.
CNBC
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from CNBC.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
CNBC (www.cnbc.com), a Tier B publisher, filed this report on . CurrentWire published this page 11 minutes later, on .
Signal breakdown
CurrentWire ranked this story 57.8 of 100 in the snapshot this page was rendered from.
- Freshness
- 31.8 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 4.5 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 31.8 of 35. How each signal is calculated.
Filed under Business · International · News.
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.